Hormone Therapy Raises Women's Risk for Bone Loss

Share
Copy

Many women on aromatase inhibitors are also prescribed bone-strengthening medications like bisphosphonates, said Lillie Shockney, administrative director at Johns Hopkins Breast Clinical Programs. But recent findings suggest that even bisphosphonates can raise a woman's risk of femur fractures.

"It is important for the primary care doctor and the medical oncologist to discuss this before automatically doing so (prescribing bisphosphonates), as these bone-building agents are not side-effect free either," said Shockney.

Most importantly, the way to prevent bone loss is simple: women need to stay active.

"Brisk walking several times a day or hopping on a treadmill is an effective way to keep bones strong," said Shockney. "Bone density should be reassessed periodically while on hormonal therapy and beyond."

Page
  • 1
  • |
  • 2
Join the Discussion
You are using an outdated version of Internet Explorer. Please click here to upgrade your browser in order to comment.
blog comments powered by Disqus
 
You Might Also Like...